Actuate Therapeutics, Inc. (NASDAQ: ACTU) ('Actuate” or the 'Company”), a clinical-stage biopharmaceutical company focused on ...
Fast Track designation designed to facilitate the development, and expedite the review, of drugs to treat serious conditions ...
Amid news of the splashy $4.8 billion Amicus buy, BioMarin has slipped in the discontinuation of a genetic liver disease ...
Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.
In recovery from methamphetamine and with a mind toward starting anew, Ambrose Haynes spent six months on housing waitlists.
AC Immune receives a "Buy" rating, driven by positive phase 2 VacSYn trial results for ACI-7104.056 in early Parkinson's Disease. Click to read why ACIU is a Buy.
Register Free: https://www.appliedclinicaltrialsonline.com/act_w/trial-workflows ...
(ORR) and 92% disease control rate (DCR) observed with MICVO as monotherapy in 2L+ R/M HNSCC at 5.4 mg/kg 71% confirmed ORR ...
Abiogen Pharma is a recognized leader in the discovery and development of bisphosphonates including the advancement of neridronate. Neridronate was approved in Italy based on the safety and efficacy ...
BioRender helps scientists draw biological diagrams more easily and communicate more efficiently. It's used by half a million ...
TH103 showed mean 10-letter gain in visual acuity and rapid, robust anatomic improvement at Month 1, following a single injectionTH103 was ...
Pharmaceutical Separation Science Session Day two of HPLC 2025 concluded with a session on pharmaceutical separations chaired ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback